Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Short-term Investments: 2022-2023

Historic Short-term Investments for Oncology Institute (TOI) over the last 2 years, with FY2023 value amounting to $49.4 million.

  • Oncology Institute's Short-term Investments fell 342.05% to $9.9 million in Q2 2024 from the same period last year, while for Jun 2024 it was $9.9 million, marking a year-over-year decrease of 342.05%. This contributed to the annual value of $49.4 million for FY2023, which is 1744.1% down from last year.
  • Per Oncology Institute's latest filing, its Short-term Investments stood at $49.4 million for FY2023, which was down 1744.1% from $59.8 million recorded in FY2022.
  • Oncology Institute's 5-year Short-term Investments high stood at $59.8 million for FY2022, and its period low was $49.4 million during FY2023.